Michael is a Marie Skłodowska-Curie PhD fellow at the University of Cambridge. In his PhD, he is developing statistical models to identify mutational processes that are actively driving tumor development and resistance. His interest is broadly in probabilistic modeling and machine learning applications in the biological and medical sciences, particularly in genomics.